XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31

EXICURE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$1.03−0.09 (-8.04%)

Close on Oct 19, 2026

Market cap: $6.57M
P/E (TTM): –
Dividend yield: –

Fundamental chart

Pick a measure to chart its full history

$0FY2025

Where these numbers come from

Parsed from the XBRL in Exicure's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-5 reverse split on Aug 28, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is XCUR.

Company	Revenue	Growth
VCNX	$601.00K	+5.4%
RGBP	$236.56K	0.0%
XCUR	$0	–
SCNX	–	–
ERNA	–	–
ANIX	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 8
Held by institutions: 2.1%
Auditor: Marcum LLP
SEC CIK: 1698530

Advertisement
300 × 250